- Home
- CDIO vs TRIB Comparison
CDIO vs TRIB Comparison
Compare CDIO & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- TRIB
- Stock Information
- Founded
- CDIO 2017
- TRIB 1992
- Country
- CDIO United States
- TRIB Ireland
- Employees
- CDIO N/A
- TRIB N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CDIO Health Care
- TRIB Health Care
- Exchange
- CDIO Nasdaq
- TRIB Nasdaq
- Market Cap
- CDIO 23.6M
- TRIB 25.5M
- IPO Year
- CDIO N/A
- TRIB N/A
- Fundamental
- Price
- CDIO $0.33
- TRIB $0.59
- Analyst Decision
- CDIO Buy
- TRIB
- Analyst Count
- CDIO 1
- TRIB 0
- Target Price
- CDIO $2.00
- TRIB N/A
- AVG Volume (30 Days)
- CDIO 807.0K
- TRIB 37.2K
- Earning Date
- CDIO 05-14-2025
- TRIB 05-22-2025
- Dividend Yield
- CDIO N/A
- TRIB N/A
- EPS Growth
- CDIO N/A
- TRIB N/A
- EPS
- CDIO N/A
- TRIB N/A
- Revenue
- CDIO $34,890.00
- TRIB $59,126,000.00
- Revenue This Year
- CDIO $1,434.82
- TRIB $11.63
- Revenue Next Year
- CDIO $4,661.91
- TRIB $10.13
- P/E Ratio
- CDIO N/A
- TRIB N/A
- Revenue Growth
- CDIO 104.45
- TRIB N/A
- 52 Week Low
- CDIO $0.19
- TRIB $0.56
- 52 Week High
- CDIO $1.77
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- CDIO 35.24
- TRIB 39.15
- Support Level
- CDIO $0.30
- TRIB $0.56
- Resistance Level
- CDIO $0.40
- TRIB $0.71
- Average True Range (ATR)
- CDIO 0.05
- TRIB 0.04
- MACD
- CDIO -0.01
- TRIB -0.00
- Stochastic Oscillator
- CDIO 21.16
- TRIB 25.00
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.